6.10
Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applicati…
Adrenergic agonists or sympathomimetics are vital during life-threatening reactions such as allergic reactions or hypovolemic shock.
Adrenaline administered parenterally relieves symptoms of severe anaphylaxis by suppressing mast cell mediator release. ꞵ2 -agonists like salbutamol also help relieve bronchial asthma.
Treating shock involves stabilizing blood flow and pressure using pressor agents. ꞵ1- agonists increase the heart rate and contractility, while α1 -agonists increase peripheral resistance. Dopamine is administered as a vasodilator and helps activate adrenoceptors.
Adrenaline or phenylephrine compresses help control excessive bleeding.
Catecholamine potentiators like amphetamine and methylphenidate are administered to patients with narcolepsy —to promote wakefulness, or ADHD —to control impulsiveness and improve attention span. Amphetamines also exert anorectic effects.
α -agonists help relieve congestion in colds, sinusitis, and rhinitis. Phenylephrine is also used in mydriatic eyedrops for ocular examinations.
Miscellaneously, the β2-agonist ritodrine is used as a uterine relaxant, while the β3-selective mirabegron helps treat urinary incontinence.
View the full transcript and gain access to JoVE Core videos
Q1: How does epinephrine treat severe anaphylaxis?
Epinephrine administered parenterally relieves severe anaphylaxis symptoms by suppressing mast cell mediator release, including histamine. This rapid action prevents airway narrowing, itching, hives, and edema, making it essential in life-threatening allergic reactions. Its effectiveness in emergency settings makes it a first-line treatment for anaphylaxis.
Q2: What role do beta-agonists play in treating asthma?
Beta-2 agonists like salbutamol act as bronchodilators, relieving bronchial asthma by relaxing airway smooth muscle. Selective beta-2 agonists such as salmeterol provide effective symptom relief in respiratory conditions. These agents are commonly used to restore normal breathing in asthma patients.
Q3: How do pressor agents stabilize blood pressure in shock?
Pressor agents increase blood pressure and heart rate through different mechanisms: beta-1 agonists increase heart contractility and rate, while alpha-1 agonists increase peripheral resistance. Dopamine acts as a vasodilator and stimulates adrenoceptors to support circulation. Together, these agents stabilize blood flow during cardiogenic and hypovolemic shock.
Q4: Why are catecholamine potentiators used for narcolepsy and ADHD?
Amphetamine and methylphenidate are indirect-acting agonists that enhance catecholamine effects in the central nervous system. These agents promote wakefulness in narcolepsy patients and control impulsiveness while improving attention in ADHD. Amphetamines also produce anorectic effects, reducing appetite and supporting therapeutic outcomes.
Q5: What are the clinical applications of alpha-agonists in nasal and ocular conditions?
Alpha-agonists relieve nasal congestion in colds, sinusitis, and rhinitis by constricting blood vessels. Phenylephrine is also used as a mydriatic in eyedrops for fundus examination during ocular assessments. These agents provide symptomatic relief and diagnostic support across multiple clinical settings.
Q6: How do adrenergic agonists control bleeding and treat urinary incontinence?
Adrenaline and phenylephrine compress blood vessels to control excessive bleeding through vasoconstriction. Beta-3 selective agonists like mirabegron relax the detrusor muscle, treating urinary incontinence. Additionally, the beta-2 agonist ritodrine acts as a uterine relaxant in obstetric applications, expanding therapeutic utility.
Q7: What distinguishes direct-acting from indirect-acting adrenergic agonists therapeutically?
Direct-acting agonists like epinephrine and phenylephrine bind directly to adrenoceptors for immediate effects in emergencies and local applications. Indirect-acting agents like amphetamine enhance endogenous catecholamine release, providing sustained CNS effects for conditions like narcolepsy and ADHD. Each mechanism suits different clinical needs and timeframes.